CicaHuntek Chemical Technology Taiwan Co Ltd reported QQ2 2024 revenue of 751,302,500 TWD, up 31.21% year over year, with quarterly flat growth of 0.00%. The quarter delivered strong gross margins (27.37%) and a healthy EBITDA margin of 44.18%, culminating in an operating margin of 20.53% and net margin of 15.71% with net income of 118,003,000 TWD and diluted EPS of 3.55. Despite robust profitability, operating cash flow was negative at 92,420,500 TWD, driven by working capital dynamics and non-cash items, contributing to negative free cash flow of 93,169,000 TWD for the quarter. The balance sheet shows a substantial liquidity position, with cash and short-term investments totaling 1,193,423,000 TWD and total assets of 2,989,694,000 TWD. Leverage remains moderate (total debt 661,873,000 TWD; equity 1,030,492,000 TWD; debt-to-equity ~0.64), and liquidity metrics are solid (current ratio 1.53, quick ratio 1.18, cash ratio 0.34). The reported net debt figure (42.28m) appears inconsistent with the cash balance and should be interpreted with caution; a standard calculation suggests a material net cash position. Going forward, management did not publish explicit QQ3 guidance in the press materials provided, so investors should monitor backlog/order intake, working capital normalization, and any capex-driven demand patterns in Asia. Overall, the company demonstrates a constructive earnings profile, but cash conversion will be a key area to watch.